1. Changes in lecithin: cholesterol acyltransferase, cholesteryl ester transfer protein and paraoxonase-1 activities in patients with colorectal cancer
   Marija Mihajlovic et al, 2019, Clinical Biochemistry CrossRef
2. A method of delivering an anti-p21Ras single-chain antibody fragment to tumor sites in vivo
   Peng Wang et al, 2022, Journal of Drug Delivery Science and Technology CrossRef
3. RGD-p21Ras-scFv expressed prokaryotically on a pilot scale inhibits ras-driven colorectal cancer growth by blocking p21Ras-GTP
   Peng Lin et al, 2024, BMC Cancer CrossRef
4. The immunoreactivity of the anti-p21Ras single-chain fragment variant KGH-R1 and its predicted binding sites to p21Ras
   Peng Wang et al, 2020, Immunotherapy CrossRef
5. Correlates of Cancer-Related Fatigue among Colorectal Cancer Patients Undergoing Postoperative Adjuvant Therapy Based on the Theory of Unpleasant Symptoms
   Song Wang et al, 2022, Current Oncology CrossRef
6. Recombinant Adenovirus KGHV500 and CIK Cells Codeliver Anti-p21-Ras scFv for the Treatment of Gastric Cancer with Wild-Type Ras Overexpression
   Mingjuan Wang et al, 2018, Molecular Therapy - Oncolytics CrossRef
7. RGD4C peptide mediates anti-p21Ras scFv entry into tumor cells and produces an inhibitory effect on the human colon cancer cell line SW480
   Chen-Chen Huang et al, 2021, BMC Cancer CrossRef
8. Anticancer activity of limonene: A systematic review of target signaling pathways
   Heitor Gomes de Araújo‐Filho et al, 2021, Phytotherapy Research CrossRef
9. Gene master regulators of papillary and anaplastic thyroid cancers
   Dumitru A. Iacobas et al, 2018, Oncotarget CrossRef